Radiogenomics and the DNA damage response: opportunities for biomarker-guided radiosensitization in pancreatic cancer - Top-Institutions - MDSpire

Radiogenomics and the DNA damage response: opportunities for biomarker-guided radiosensitization in pancreatic cancer

  • By

  • Marie Nour Karam

  • Joseph Hajj

  • Christopher H. Crane

  • Paul Ramia

  • Fady Geara

  • Nadim Hamadeh

  • Jacob G. Scott

  • Stephen Grobmyer

  • Rachael Almond

  • Eileen M. O’Reilly

  • Carla Hajj

  • June 8, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Cedars-Sinai Medical Center
    Cedars-Sinai Medical Center

    Los Angeles, CA

    Key Differentiators

    • Oncology

  • #2

    Samuel Oschin Comprehensive Cancer Center
    Samuel Oschin Comprehensive Cancer Center

    Los Angeles, CA

    Key Differentiators

    • Oncology

  • #3

    University of Pittsburgh Medical Center
    University of Pittsburgh Medical Center

    Pittsburgh, PA

    Key Differentiators

    • Oncology

Original Source(s)

Radiogenomics and the DNA damage response: opportunities for biomarker-guided radiosensitization in pancreatic cancer

  • by Marie Nour Karam, Joseph Hajj, Christopher H. Crane, Paul Ramia, Fady Geara, Nadim Hamadeh, Jacob G. Scott, Stephen Grobmyer, Rachael Almond, Eileen M. O’Reilly, Carla Hajj

  • June 8, 2026

Related Content

Value of point-of-care ultrasound in the early identification of left ventricular dysfunction and prognostic assessment in cancer patients complicated by sepsis

Epidemiology, outcomes of treatment, and survival of cervical cancer in Kazakhstan: a nationwide population-based study

Editorial: Autoantibodies in cancer: diagnostic, prognostic, and therapeutic potential